Synthesis and biological studies of a new series of 5-heteroarylcarbamoylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine s as human A(3) adenosine receptor antagonists. Influence of the heteroaryl substituent on binding affinity and molecular modeling investigations